Cellular decisions in cardiac outflow tract and coronary development: An act by VEGF and NOTCH

Differentiation

Volumn 84, Issue 1, 2012, Pages 62-78

  van den Akker, Nynke M S ^a,b   Caolo, Vincenza ^a   Molin, Daniël G M ^a,b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Cardiac outflow tract; Coronary system; Development; NOTCH; VEGF

Indexed keywords

CELL PROTEIN; NOTCH RECEPTOR; PROTEIN DLL4; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 3;

ANGIOGENESIS; CELL COMMUNICATION; CELL FUNCTION; CELL INTERACTION; CELL MATURATION; CONGENITAL HEART MALFORMATION; CORONARY DEVELOPMENT; DISEASE SEVERITY; DNA POLYMORPHISM; EPITHELIAL MESENCHYMAL TRANSITION; FEEDBACK SYSTEM; GENE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HEART DEVELOPMENT; HEART MUSCLE CELL; HEART OUTFLOW TRACT DEVELOPMENT; HUMAN; MOLECULAR INTERACTION; NONHUMAN; NOTCH GENE; NOTCH1 GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; TISSUE DIFFERENTIATION; VEGF GENE;

ANIMALS; ATHEROSCLEROSIS; CELL DIFFERENTIATION; CORONARY VESSELS; DISEASE MODELS, ANIMAL; GENETIC PREDISPOSITION TO DISEASE; HEART; HEART DEFECTS, CONGENITAL; HEART VALVES; HUMANS; MICE; MUTATION; MYOCYTES, CARDIAC; POLYMORPHISM, GENETIC; RECEPTOR, NOTCH1; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ANIMALIA; MUS MUSCULUS;

EID: 84863106353     PISSN: 03014681     EISSN: 14320436     Source Type: Journal    
DOI: 10.1016/j.diff.2012.04.002     Document Type: Review

References (240)

1. Adams R.H., Eichmann A. Axon guidance molecules in vascular patterning. Cold Spring Harbor Perspectives Biology 2010, a001875.
2. Aicher D., Urbich C., Zeiher A., Dimmeler S., Schafers H.J. Endothelial nitric oxide synthase in bicuspid aortic valve disease. The Annals of Thoracic Surgery 2007, 1290-1294.
3. Alexander S.M., Jackson K.J., Bushnell K.M., McGuire P.G. Spatial and temporal expression of the 72-kDa type IV collagenase (MMP-2) correlates with development and differentiation of valves in the embryonic avian heart. Developmental Dynamics : An Official Publication of the American Association of Anatomists 1997, 261-268.
4. Armstrong E.J., Bischoff J. Heart valve development: endothelial cell signaling and differentiation. Circulation Research 2004, 459-470.
5. Azambuja A.P., Portillo-Sanchez V., Rodrigues M.V., Omae S.V., Schechtman D., Strauss B.E., Costanzi-Strauss E., Krieger J.E., Perez-Pomares J.M., Xavier-Neto J. Retinoic acid and VEGF delay smooth muscle relative to endothelial differentiation to coordinate inner and outer coronary vessel wall morphogenesis. Circulation Research 2010, 204-216.
6. Azhar M., Schultz J.J., Grupp I., Dorn G.W., Meneton P., Molin D.G., Gittenberger-De Groot A.C., Doetschman T. Transforming growth factor beta in cardiovascular development and function. Cytokine & Growth Factor Reviews 2003, 391-407.
7. Bajolle F., Zaffran S., Kelly R.G., Hadchouel J., Bonnet D., Brown N.A., Buckingham M.E. Rotation of the myocardial wall of the outflow tract is implicated in the normal positioning of the great arteries. Circulation Research 2006, 421-428.
8. Bartelings M.M., Wenink A.C., Gittenberger-De Groot A.C., Oppenheimer-Dekker A. Contribution of the aortopulmonary septum to the muscular outlet septum in the human heart. Acta morphologica Neerlando-Scandinavica 1986, 181-192.
9. Bartram U., Molin D.G., Wisse L.J., Mohamad A., Sanford L.P., Doetschman T., Speer C.P., Poelmann R.E., Gittenberger-De Groot A.C. Double-outlet right ventricle and overriding tricuspid valve reflect disturbances of looping, myocardialization, endocardial cushion differentiation, and apoptosis in TGF-beta(2)-knockout mice. Circulation 2001, 2745-2752.
10. Bates D.O. Vascular endothelial growth factors and vascular permeability. Cardiovascular Research 2010, 262-271.
11. Bates D.O., Harper S.J. Regulation of vascular permeability by vascular endothelial growth factors. Vascular Pharmacology 2002, 225-237.
12. Bauer R.C., Laney A.O., Smith R., Gerfen J., Morrissette J.J., Woyciechowski S., Garbarini J., Loomes K.M., Krantz I.D., Urban Z., Gelb B.D., Goldmuntz E., Spinner N.B. Jagged1 (JAG1) mutations in patients with tetralogy of fallot or pulmonic stenosis. Human Mutation 2010, 594-601.
13. Benedito R., Trindade A., Hirashima M., Henrique D., da Costa L.L., Rossant J., Gill P.S., Duarte A. Loss of Notch signalling induced by Dll4 causes arterial calibre reduction by increasing endothelial cell response to angiogenic stimuli. BMC. Developmental Biology (Amsterdam, Netherlands) 2008, 117.
14. Bentley K., Gerhardt H., Bates P.A. Agent-based simulation of notch-mediated tip cell selection in angiogenic sprout initialisation. Journal of Theoretical Biology 2008, 25-36.
15. Bevan H.S., Van Den Akker N.M., Qiu Y., Polman J.A., Foster R.R., Yem J., Nishikawa A., Satchell S.C., Harper S.J., Gittenberger-De Groot A.C., Bates D.O. The alternatively spliced anti-angiogenic family of VEGF isoforms VEGFxxxb in human kidney development. Nephron Physiology 2008, 57-67.
16. Black B.L. Transcriptional pathways in second heart field development. Seminars in Cell and Developmental Biology 2007, 67-76.
17. Bogers A.J., Gittenberger-De Groot A.C., Poelmann R.E., Peault B.M., Huysmans H.A. Development of the origin of the coronary arteries, a matter of ingrowth or outgrowth? Anat. Embryology (Berlin) 1989, 437-441.
18. Boot M.J., Gittenberger-De Groot A.C., Van I.L., Hierck B.P., Poelmann R.E. Spatiotemporally separated cardiac neural crest subpopulations that target the outflow tract septum and pharyngeal arch arteries. The Anatomical Record Part A, Discoveries in Molecular, Cellular, and Evolutionary Biology 2003, 1009-1018.
19. Boyer B., Valles A.M., Edme N. Induction and regulation of epithelial-mesenchymal transitions. Biochemical Pharmacology 2000, 1091-1099.
20. Boyer J., Crosnier C., Driancourt C., Raynaud N., Gonzales M., Hadchouel M., Meunier-Rotival M. Expression of mutant JAGGED1 alleles in patients with Alagille syndrome. Human Genetics 2005, 445-453.
21. Browner N.C., Dey N.B., Bloch K.D., Lincoln T.M. Regulation of cGMP-dependent protein kinase expression by soluble guanylyl cyclase in vascular smooth muscle cells. Journal of Biological Chemistry 2004, 46631-46636.
22. Camenisch T.D., Molin D.G., Person A., Runyan R.B., Gittenberger-De Groot A.C., McDonald J.A., Klewer S.E. Temporal and distinct TGFbeta ligand requirements during mouse and avian endocardial cushion morphogenesis. Developmental Biology (Amsterdam, Netherlands) 2002, 170-181.
23. Cano A., Perez-Moreno M.A., Rodrigo I., Locascio A., Blanco M.J., del Barrio M.G., Portillo F., Nieto M.A. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nature Cell Biology 2000, 76-83.
24. Caolo V., Van Den Akker N.M., Verbruggen S., Donners M.M., Swennen G., Schulten H., Waltenberger J., Post M.J., Molin D.G. Feed-forward signaling by membrane-bound ligand receptor circuit: the case of NOTCH DELTA-like 4 ligand in endothelial cells. Journal of Biological Chemistry 2010, 40681-40689.
25. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis Nature Medicine 2000, 389-395.
26. Carmeliet P., Ferreira V., Breier G., Pollefeyt S., Kieckens L., Gertsenstein M., Fahrig M., Vandenhoeck A., Harpal K., Eberhardt C., Declercq C., Pawling J., Moons L., Collen D., Risau W., Nagy A. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996, 435-439.
27. Carmeliet P., Ng Y.S., Nuyens D., Theilmeier G., Brusselmans K., Cornelissen I., Ehler E., Kakkar V.V., Stalmans I., Mattot V., Perriard J.C., Dewerchin M., Flameng W., Nagy A., Lupu F., Moons L., Collen D., D'Amore P.A., Shima D.T. Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Nature Medicine (New York, NY, United States) 1999, 495-502.
28. Chang A.C., Fu Y., Garside V.C., Niessen K., Chang L., Fuller M., Setiadi A., Smrz J., Kyle A., Minchinton A., Marra M., Hoodless P.A., Karsan A. Notch initiates the endothelial-to-mesenchymal transition in the atrioventricular canal through autocrine activation of soluble guanylyl cyclase. Developmental Cell 2011, 288-300.
29. Chang C.P., Neilson J.R., Bayle J.H., Gestwicki J.E., Kuo A., Stankunas K., Graef I.A., Crabtree G.R. A field of myocardial-endocardial NFAT signaling underlies heart valve morphogenesis. Cell (Cambridge, MA, United States) 2004, 649-663.
30. Chen Y., Dawes P.T., Packham J.C., Mattey D.L. Interaction between smoking and polymorphism in the promoter region of the VEGFA gene is associated with ischemic heart disease and myocardial infarction in rheumatoid arthritis. The Journal of Rheumatology 2011, 802-809.
31. Christiansen J.H., Coles E.G., Wilkinson D.G. Molecular control of neural crest formation, migration and differentiation. Current Opinion in Cell Biology 2000, 719-724.
32. Copeland J.N., Feng Y., Neradugomma N.K., Fields P.E., Vivian J.L. Notch signaling regulates remodeling and vessel diameter in the extraembryonic yolk sac. BMC. Developmental Biology (Amsterdam, Netherlands) 2011, 12.
33. Cornell R.A., Eisen J.S. Notch in the pathway: the roles of Notch signaling in neural crest development. Seminars in Cell and Developmental Biology 2005, 663-672.
34. Cossette S., Misra R. The identification of different endothelial cell populations within the mouse proepicardium. Developmental dynamics : An official publication of the American Association of Anatomists 2011, 2344-2353.
35. Coultas L., Nieuwenhuis E., Anderson G.A., Cabezas J., Nagy A., Henkelman R.M., Hui C.C., Rossant J. Hedgehog regulates distinct vascular patterning events through VEGF-dependent and -independent mechanisms. Blood 2010, 653-660.
36. Davis M.E., Grumbach I.M., Fukai T., Cutchins A., Harrison D.G. Shear stress regulates endothelial nitric-oxide synthase promoter activity through nuclear factor kappaB binding. Journal of Biological Chemistry 2004, 163-168.
37. Davis R.L., Turner D.L. Vertebrate hairy and Enhancer of split related proteins: transcriptional repressors regulating cellular differentiation and embryonic patterning. Oncogene 2001, 8342-8357.
38. del Monte G., Casanova J.C., Guadix J.A., MacGrogan D., Burch J.B., Perez-Pomares J.M., de la Pompa J.L. Differential Notch signaling in the epicardium is required for cardiac inflow development and coronary vessel morphogenesis. Circulation Research 2011, 824-836.
39. Delwig A., Rand M.D. Kuz and TACE can activate Notch independent of ligand. Cellular and Molecular Life Sciences 2008, 2232-2243.
40. Diez H., Fischer A., Winkler A., Hu C.J., Hatzopoulos A.K., Breier G., Gessler M. Hypoxia-mediated activation of Dll4-Notch-Hey2 signaling in endothelial progenitor cells and adoption of arterial cell fate. Experimental Cell Research 2007, 1-9.
41. Domenga V., Fardoux P., Lacombe P., Monet M., Maciazek J., Krebs L.T., Klonjkowski B., Berrou E., Mericskay M., Li Z., Tournier-Lasserve E., Gridley T., Joutel A. Notch3 is required for arterial identity and maturation of vascular smooth muscle cells. Genes and Development 2004, 2730-2735.
42. Donners M.M., Wolfs I.M., Olieslagers S., Mohammadi-Motahhari Z., Tchaikovski V., Heeneman S., van Buul J.D., Caolo V., Molin D.G., Post M.J., Waltenberger J. A disintegrin and metalloprotease 10 is a novel mediator of vascular endothelial growth factor-induced endothelial cell function in angiogenesis and is associated with atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular biology 2010, 2188-2195.
43. Donovan J., Kordylewska A., Jan Y.N., Utset M.F. Tetralogy of fallot and other congenital heart defects in Hey2 mutant mice. Current Biology 2002, 1605-1610.
44. Dor Y., Camenisch T.D., Itin A., Fishman G.I., McDonald J.A., Carmeliet P., Keshet E. A novel role for VEGF in endocardial cushion formation and its potential contribution to congenital heart defects. Development (Cambridge, United Kingdom) 2001, 1531-1538.
45. Dor Y., Klewer S.E., McDonald J.A., Keshet E., Camenisch T.D. VEGF modulates early heart valve formation. The Anatomical Record Part A, Discoveries in Molecular, Cellular, and Evolutionary Biology 2003, 202-208.
46. Drake C.J., Wessels A., Trusk T., Little C.D. Elevated vascular endothelial cell growth factor affects mesocardial morphogenesis and inhibits normal heart bending. Developmental dynamics : An official publication of the American Association of Anatomists 2006, 10-18.
47. Duarte A., Hirashima M., Benedito R., Trindade A., Diniz P., Bekman E., Costa L., Henrique D., Rossant J. Dosage-sensitive requirement for mouse Dll4 in artery development. Genes and Development 2004, 2474-2478.
48. Eisenberg L.M., Markwald R.R. Molecular regulation of atrioventricular valvuloseptal morphogenesis. Circulation Research 1995, 1-6.
49. Eldadah Z.A., Hamosh A., Biery N.J., Montgomery R.A., Duke M., Elkins R., Dietz H.C. Familial tetralogy of fallot caused by mutation in the jagged1 gene. Human Molecular Genetics 2001, 163-169.
50. Ellertsdottir E., Lenard A., Blum Y., Krudewig A., Herwig L., Affolter M., Belting H.G. Vascular morphogenesis in the zebrafish embryo. Developmental Biology (Amsterdam, Netherlands) 2010, 56-65.
51. Enciso J.M., Gratzinger D., Camenisch T.D., Canosa S., Pinter E., Madri J.A. Elevated glucose inhibits VEGF-A-mediated endocardial cushion formation: modulation by PECAM-1 and MMP-2. Journal of Cell Biology 2003, 605-615.
52. Epstein J.A., Li J., Lang D., Chen F., Brown C.B., Jin F., Lu M.M., Thomas M., Liu E., Wessels A., Lo C.W. Migration of cardiac neural crest cells in Splotch embryos. Development (Cambridge, United Kingdom) 2000, 1869-1878.
53. Eralp I., Lie-Venema H., DeRuiter M.C., Van Den Akker N.M., Bogers A.J., Mentink M.M., Poelmann R.E., Gittenberger-De Groot A.C. Coronary artery and orifice development is associated with proper timing of epicardial outgrowth and correlated Fas-ligand-associated apoptosis patterns. Circulation Research 2005, 526-534.
54. Feng Q., Song W., Lu X., Hamilton J.A., Lei M., Peng T., Yee S.P. Development of heart failure and congenital septal defects in mice lacking endothelial nitric oxide synthase. Circulation 2002, 873-879.
55. Feng X., Krebs L.T., Gridley T. Patent ductus arteriosus in mice with smooth muscle-specific Jag1 deletion. Development (Cambridge, United Kingdom) 2010, 4191-4199.
56. Ferguson J.E., Kelley R.W., Patterson C. Mechanisms of endothelial differentiation in embryonic vasculogenesis. Arteriosclerosis, Thrombosis, and Vascular Biology 2005, 2246-2254.
57. Ferrara N., Carver-Moore K., Chen H., Dowd M., Lu L., O'Shea K.S., Powell-Braxton L., Hillan K.J., Moore M.W. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996, 439-442.
58. Ferrara N., Gerber H.P., LeCouter J. The biology of VEGF and its receptors. Nature Medicine (New York, NY, United States) 2003, 669-676.
59. Fischer A., Klamt B., Schumacher N., Glaeser C., Hansmann I., Fenge H., Gessler M. Phenotypic variability in Hey2 -/- mice and absence of HEY2 mutations in patients with congenital heart defects or Alagille syndrome. Mammalian Genome : Official Journal of the International Mammalian Genome Society 2004, 711-716.
60. Fischer A., Schumacher N., Maier M., Sendtner M., Gessler M. The Notch target genes Hey1 and Hey2 are required for embryonic vascular development. Genes and Development 2004, 901-911.
61. Fischer A., Steidl C., Wagner T.U., Lang E., Jakob P.M., Friedl P., Knobeloch K.P., Gessler M. Combined loss of Hey1 and HeyL causes congenital heart defects because of impaired epithelial to mesenchymal transition. Circulation Research 2007, 856-863.
62. Fong G.H., Rossant J., Gertsenstein M., Breitman M.L. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 1995, 66-70.
63. Francis J.C., Radtke F., Logan M.P. Notch1 signals through Jagged2 to regulate apoptosis in the apical ectodermal ridge of the developing limb bud. Developmental dynamics : An official publication of the American Association of Anatomists 2005, 1006-1015.
64. Funahashi Y., Shawber C.J., Sharma A., Kanamaru E., Choi Y.K., Kitajewski J. Notch modulates VEGF action in endothelial cells by inducing Matrix Metalloprotease activity. Vascular Cell 2011, 2.
65. Gale N.W., Dominguez M.G., Noguera I., Pan L., Hughes V., Valenzuela D.M., Murphy A.J., Adams N.C., Lin H.C., Holash J., Thurston G., Yancopoulos G.D. Haploinsufficiency of delta-like 4 ligand results in embryonic lethality due to major defects in arterial and vascular development. Proceedings of the National Academy of Sciences of the United States of America 2004, 15949-15954.
66. Garg V., Muth A.N., Ransom J.F., Schluterman M.K., Barnes R., King I.N., Grossfeld P.D., Srivastava D. Mutations in NOTCH1 cause aortic valve disease. Nature 2005, 270-274.
67. Ge C., Stanley P. Effects of varying Notch1 signal strength on embryogenesis and vasculogenesis in compound mutant heterozygotes. BMC Developmental Biology 2010, 36.
68. Gerhardt H. VEGF and endothelial guidance in angiogenic sprouting. Organogenesis 2008, 241-246.
69. Gittenberger-De Groot A.C., Bartelings M.M., Bogers A.J., Boot M.J., Poelmann R.E. The embryology of the common arterial trunk. Progress in Pediatric Cardiology 2002, 1-8.
70. Gittenberger-De Groot A.C., Bartelings M.M., DeRuiter M.C., Poelmann R.E. Normal Cardiac Development 1996, 1-14.
71. Gittenberger-De Groot A.C., Bartelings M.M., DeRuiter M.C., Poelmann R.E. Basics of cardiac development for the understanding of congenital heart malformations. Pediatric Research 2005, 169-176.
72. Gittenberger-De Groot A.C., Eralp I., Lie-Venema H., Bartelings M.M., Poelmann R.E. Development of the coronary vasculature and its implications for coronary abnormalities in general and specifically in pulmonary atresia without ventricular septal defect. Acta paediatrica (Oslo, Norway : 1992) Supplement 2004, 13-19.
73. Greenway S.C., Pereira A.C., Lin J.C., DePalma S.R., Israel S.J., Mesquita S.M., Ergul E., Conta J.H., Korn J.M., McCarroll S.A., Gorham J.M., Gabriel S., Altshuler D.M., Quintanilla-Dieck M.L., Artunduaga M.A., Eavey R.D., Plenge R.M., Shadick N.A., Weinblatt M.E., De Jager P.L., Hafler D.A., Breitbart R.E., Seidman J.G., Seidman C.E. De novo copy number variants identify new genes and loci in isolated sporadic tetralogy of Fallot. Nature Genetics 2009, 931-935.
74. Grego-Bessa J., Luna-Zurita L., del M.G., Bolos V., Melgar P., Arandilla A., Garratt A.N., Zang H., Mukouyama Y.S., Chen H., Shou W., Ballestar E., Esteller M., Rojas A., Perez-Pomares J.M., de la Pompa J.L. Notch signaling is essential for ventricular chamber development. Developmental Cell 2007, 415-429.
75. Gridley T. Notch signaling and inherited disease syndromes. Human Molecular Genetics 2003, R9-13.
76. Grieskamp T., Rudat C., Ludtke T.H., Norden J., Kispert A. Notch signaling regulates smooth muscle differentiation of epicardium-derived cells. Circulation Research 2011, 813-823.
77. Griffin H.R., Hall D.H., Topf A., Eden J., Stuart A.G., Parsons J., Peart I., Deanfield J.E., O'Sullivan J., Babu-Narayan S.V., Gatzoulis M.A., Bu'lock F.A., Bhattacharya S., Bentham J., Farrall M., Granados R.J., Brook J.D., Burn J., Cordell H.J., Goodship J.A., Keavney B. Genetic variation in VEGF does not contribute significantly to the risk of congenital cardiovascular malformation. PLoS One 2009, e4978.
78. Hainaud P., Contreres J.O., Villemain A., Liu L.X., Plouet J., Tobelem G., Dupuy E. The role of the vascular endothelial growth factor-delta-like 4 ligand/Notch4-Ephrin B2 cascade in tumor vessel remodeling and endothelial cell functions. Cancer Research 2006, 8501-8510.
79. Halayko A.J., Solway J. Molecular mechanisms of phenotypic plasticity in smooth muscle cells. Journal of Applied Physiology: Respiratory, Environmental and Exercise Physiology 2001, 358-368.
80. Harrington L.S., Sainson R.C., Williams C.K., Taylor J.M., Shi W., Li J.L., Harris A.L. Regulation of multiple angiogenic pathways by Dll4 and Notch in human umbilical vein endothelial cells. Microvascular Research 2008, 144-154.
81. Hartmann D., de S.B., Serneels L., Craessaerts K., Herreman A., Annaert W., Umans L., Lubke T., Lena I.A., von F.K., Saftig P. The disintegrin/metalloprotease ADAM 10 is essential for Notch signalling but not for alpha-secretase activity in fibroblasts. Human Molecular Genetics 2002, 2615-2624.
82. Hayashi H., Kume T. Foxc transcription factors directly regulate Dll4 and Hey2 expression by interacting with the VEGF-Notch signaling pathways in endothelial cells. PLoS One 2008, e2401.
83. Hellstrom M., Phng L.K., Hofmann J.J., Wallgard E., Coultas L., Lindblom P., Alva J., Nilsson A.K., Karlsson L., Gaiano N., Yoon K., Rossant J., Iruela-Arispe M.L., Kalen M., Gerhardt H., Betsholtz C. Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis. Nature 2007, 776-780.
84. High F.A., Jain R., Stoller J.Z., Antonucci N.B., Lu M.M., Loomes K.M., Kaestner K.H., Pear W.S., Epstein J.A. Murine Jagged1/Notch signaling in the second heart field orchestrates Fgf8 expression and tissue-tissue interactions during outflow tract development. Journal of Clinical Investigation 2009, 1986-1996.
85. High F.A., Lu M.M., Pear W.S., Loomes K.M., Kaestner K.H., Epstein J.A. Endothelial expression of the Notch ligand Jagged1 is required for vascular smooth muscle development. Proceedings of the National Academy of Sciences of the United States of America 2008, 1955-1959.
86. High F.A., Zhang M., Proweller A., Tu L., Parmacek M.S., Pear W.S., Epstein J.A. An essential role for Notch in neural crest during cardiovascular development and smooth muscle differentiation. Journal of Clinical Investigation 2007, 353-363.
87. Hirashima M., Suda T. Differentiation of arterial and venous endothelial cells and vascular morphogenesis. Endothelium : Journal of Endothelial Cell Research 2006, 137-145.
88. Hiratsuka S., Nakao K., Nakamura K., Katsuki M., Maru Y., Shibuya M. Membrane fixation of vascular endothelial growth factor receptor 1 ligand-binding domain is important for vasculogenesis and angiogenesis in mice. Molecular and Cellular Biology 2005, 346-354.
89. Hoffmann A.D., Peterson M.A., Friedland-Little J.M., Anderson S.A., Moskowitz I.P. Sonic hedgehog is required in pulmonary endoderm for atrial septation. Development (Cambridge, United Kingdom) 2009, 1761-1770.
90. Hofmann J.J., Iruela-Arispe M.L. Notch signaling in blood vessels-Who is talking to whom about what?. Circulation Research 2007, 1556-1568.
91. Hogan B.M., Herpers R., Witte M., Helotera H., Alitalo K., Duckers H.J., Schulte-Merker S. Vegfc/Flt4 signalling is suppressed by Dll4 in developing zebrafish intersegmental arteries. Development (Cambridge, United Kingdom) 2009, 4001-4009.
92. Holden B.J., Bratt D.G., Chico T.J. Molecular control of vascular development in the zebrafish. Birth Defects Res. C. Embryo. Today 2011, 134-140.
93. Houck K.A., Leung D.W., Rowland A.M., Winer J., Ferrara N. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. Journal of Biological Chemistry 1992, 26031-26037.
94. Huang X., Saint-Jeannet J.P. Induction of the neural crest and the opportunities of life on the edge. Developmental Biology (Amsterdam, Netherlands) 2004, 1-11.
95. Hutson M.R., Kirby M.L. Neural crest and cardiovascular development: a 20-year perspective. Birth Defects Res. C. Embryo. Today 2003, 2-13.
96. Iascone M., Ciccone R., Galletti L., Marchetti D., Seddio F., Lincesso A., Pezzoli L., Vetro A., Barachetti D., Boni L., Federici D., Soto A., Comas J., Ferrazzi P., Zuffardi O. Identification of de novo mutations and rare variants in hypoplastic left heart syndrome. Clinical Genetics 2011.
97. Iso T., Hamamori Y., Kedes L. Notch signaling in vascular development. Arteriosclerosis, Thrombosis, and Vascular Biology 2003, 543-553.
98. Iso T., Kedes L., Hamamori Y. HES and HERP families: multiple effectors of the Notch signaling pathway. Journal of Cellular Physiology 2003, 237-255.
99. Jain R., Engleka K.A., Rentschler S.L., Manderfield L.J., Li L., Yuan L., Epstein J.A. Cardiac neural crest orchestrates remodeling and functional maturation of mouse semilunar valves. Journal of Clinical Investigation 2011, 422-430.
100. Jain R., Rentschler S., Epstein J.A. Notch and cardiac outflow tract development. Annals of the New York Academy of Sciences 2010, 184-190.
101. Jakobsson L., Bentley K., Gerhardt H. VEGFRs and Notch: a dynamic collaboration in vascular patterning. Biochemical Society Transactions 2009, 1233-1236.
102. Jiang X., Choudhary B., Merki E., Chien K.R., Maxson R.E., Sucov H.M. Normal fate and altered function of the cardiac neural crest cell lineage in retinoic acid receptor mutant embryos. Mechanisms of Development 2002, 115-122.
103. Jiang X., Rowitch D.H., Soriano P., McMahon A.P., Sucov H.M. Fate of the mammalian cardiac neural crest. Development (Cambridge, United Kingdom) 2000, 1607-1616.
104. Jin Z.G., Ueba H., Tanimoto T., Lungu A.O., Frame M.D., Berk B.C. Ligand-independent activation of vascular endothelial growth factor receptor 2 by fluid shear stress regulates activation of endothelial nitric oxide synthase. Circulation Research 2003, 354-363.
105. Kariyazono H., Ohno T., Khajoee V., Ihara K., Kusuhara K., Kinukawa N., Mizuno Y., Hara T. Association of vascular endothelial growth factor (VEGF) and VEGF receptor gene polymorphisms with coronary artery lesions of Kawasaki disease. Pediatric Research 2004, 953-959.
106. Kawasaki T., Kitsukawa T., Bekku Y., Matsuda Y., Sanbo M., Yagi T., Fujisawa H. A requirement for neuropilin-1 in embryonic vessel formation. Development (Cambridge, United Kingdom) 1999, 4895-4902.
107. Kelly R.G. Molecular inroads into the anterior heart field. Trends in Cardiovascular Medicine 2005, 51-56.
108. Kennard S., Liu H., Lilly B. Transforming growth factor-beta (TGF- 1) down-regulates Notch3 in fibroblasts to promote smooth muscle gene expression. Journal of Biological Chemistry 2008, 1324-1333.
109. Keyte A.L., Hutson M.R. The neural crest in cardiac congenital anomalies. Differentiation (Malden, MA, United States) 2012.
110. Kirby M.L., Gale T.F., Stewart D.E. Neural crest cells contribute to normal aorticopulmonary septation. Science 1983, 1059-1061.
111. Kitsukawa T., Shimono A., Kawakami A., Kondoh H., Fujisawa H. Overexpression of a membrane protein, neuropilin, in chimeric mice causes anomalies in the cardiovascular system, nervous system and limbs. Development (Cambridge, United Kingdom) 1995, 4309-4318.
112. Kokubo H., Miyagawa-Tomita S., Tomimatsu H., Nakashima Y., Nakazawa M., Saga Y., Johnson R.L. Targeted disruption of hesr2 results in atrioventricular valve anomalies that lead to heart dysfunction. Circulation Research 2004, 540-547.
113. Kola S., Koneti N.R., Golla J.P., Akka J., Gundimeda S.D., Mundluru H.P. Mutational analysis of JAG1 gene in non-syndromic tetralogy of Fallot children. Clinica Chimica Acta 2011, 2232-2236.
114. Kratsios P., Catela C., Salimova E., Huth M., Berno V., Rosenthal N., Mourkioti F. Distinct roles for cell-autonomous Notch signaling in cardiomyocytes of the embryonic and adult heart. Circulation Research 2010, 559-572.
115. Krebs L.T., Shutter J.R., Tanigaki K., Honjo T., Stark K.L., Gridley T. Haploinsufficient lethality and formation of arteriovenous malformations in Notch pathway mutants. Genes and Development 2004, 2469-2473.
116. Krebs L.T., Xue Y., Norton C.R., Shutter J.R., Maguire M., Sundberg J.P., Gallahan D., Closson V., Kitajewski J., Callahan R., Smith G.H., Stark K.L., Gridley T. Notch signaling is essential for vascular morphogenesis in mice. Genes and Development 2000, 1343-1352.
117. Krueger J., Liu D., Scholz K., Zimmer A., Shi Y., Klein C., Siekmann A., Schulte-Merker S., Cudmore M., Ahmed A., le N.F. Flt1 acts as a negative regulator of tip cell formation and branching morphogenesis in the zebrafish embryo. Development (Cambridge, United Kingdom) 2011, 2111-2120.
118. Laane H.M., Roest-Wagenaar J.A. Development and fusion of endocardial structures in the arterial pole of the heart of chick, rat and human embryos. Perspectives in Cardiovascular Research 1981, 267-277.
119. Laforest B., Andelfinger G., Nemer M. Loss of Gata5 in mice leads to bicuspid aortic valve. Journal of Clinical Investigation 2011, 2876-2887.
120. Lai E.C. Notch signaling: control of cell communication and cell fate. Development (Cambridge, United Kingdom) 2004, 965-973.
121. Lambrechts D., Devriendt K., Driscoll D.A., Goldmuntz E., Gewillig M., Vlietinck R., Collen D., Carmeliet P. Low expression VEGF haplotype increases the risk for tetralogy of Fallot: a family based association study. Journal of Medical Genetics 2005, 519-522.
122. Lawson N.D., Vogel A.M., Weinstein B.M. sonic hedgehog and vascular endothelial growth factor act upstream of the Notch pathway during arterial endothelial differentiation. Developmental Cell 2002, 127-136.
123. Le Caignec C., Lefevre M., Schott J.J., Chaventre A., Gayet M., Calais C., Moisan J.P. Familial deafness, congenital heart defects, and posterior embryotoxon caused by cysteine substitution in the first epidermal-growth-factor-like domain of jagged 1. American Journal of Human Genetics 2002, 180-186.
124. Lee T.C., Zhao Y.D., Courtman D.W., Stewart D.J. Abnormal aortic valve development in mice lacking endothelial nitric oxide synthase. Circulation 2000, 2345-2348.
125. Lee Y.M., Cope J.J., Ackermann G.E., Goishi K., Armstrong E.J., Paw B.H., Bischoff J. Vascular endothelial growth factor receptor signaling is required for cardiac valve formation in zebrafish. Developmental dynamics : an official publication of the American Association of Anatomists 2006, 29-37.
126. Leslie J.D., Ariza-McNaughton L., Bermange A.L., McAdow R., Johnson S.L., Lewis J. Endothelial signalling by the Notch ligand Delta-like 4 restricts angiogenesis. Development (Cambridge, United Kingdom) 2007, 839-844.
127. Licht A.H., Raab S., Hofmann U., Breier G. Endothelium-specific Cre recombinase activity in flk-1-Cre transgenic mice. Developmental Dynamics : An Official Publication of the American Association of Anatomists 2004, 312-318.
128. Lie-Venema H., Eralp I., Maas S., Gittenberger-De Groot A.C., Poelmann R.E., DeRuiter M.C. Myocardial heterogeneity in permissiveness for epicardium-derived cells and endothelial precursor cells along the developing heart tube at the onset of coronary vascularization. The Anatomical Record Part A, Discoveries in Molecular, Cellular, and Evolutionary Biology 2005, 120-129.
129. Lie-Venema H., Van Den Akker N.M.S., Bax N.A., Winter E.M., Maas S., Kerkarainen T., Hoeben R.C., DeRuiter M.C., Poelmann R.E., Gittenberger-De Groot A.C. Origin, fate and function of epicardium-derived cells (EPDCs) in normal and abnormal cardiac development. The Scientific World Journal 2007, 1777-1798.
130. Limbourg A., Ploom M., Elligsen D., Sorensen I., Ziegelhoeffer T., Gossler A., Drexler H., Limbourg F.P. Notch ligand Delta-like 1 is essential for postnatal arteriogenesis. Circulation Research 2007, 363-371.
131. Liu H., Kennard S., Lilly B. NOTCH3 expression is induced in mural cells through an autoregulatory loop that requires endothelial-expressed JAGGED1. Circulation Research 2009, 466-475.
132. Liu Z.J., Shirakawa T., Li Y., Soma A., Oka M., Dotto G.P., Fairman R.M., Velazquez O.C., Herlyn M. Regulation of Notch1 and Dll4 by vascular endothelial growth factor in arterial endothelial cells: implications for modulating arteriogenesis and angiogenesis. Molecular and Cellular Biology 2003, 14-25.
133. Lobov I.B., Renard R.A., Papadopoulos N., Gale N.W., Thurston G., Yancopoulos G.D., Wiegand S.J. Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting. Proceedings of the National Academy of Sciences of the United States of America 2007, 3219-3224.
134. Lu F., Morrissette J.J., Spinner N.B. Conditional JAG1 mutation shows the developing heart is more sensitive than developing liver to JAG1 dosage. American Journal of Human Genetics 2003, 1065-1070.
135. Markwald R., Eisenberg C., Eisenberg L., Trusk T., Sugi Y. Epithelial-mesenchymal transformations in early avian heart development. Acta Anatomica (Basel) 1996, 173-186.
136. Markwald R.R., Fitzharris T.P., Manasek F.J. Structural development of endocardial cushions. The American Journal of Anatomy 1977, 85-119.
137. May D., Gilon D., Djonov V., Itin A., Lazarus A., Gordon O., Rosenberger C., Keshet E. Transgenic system for conditional induction and rescue of chronic myocardial hibernation provides insights into genomic programs of hibernation. Proceedings of the National Academy of Sciences of the United States of America 2008, 282-287.
138. McCright B., Lozier J., Gridley T. A mouse model of Alagille syndrome: Notch2 as a genetic modifier of Jag1 haploinsufficiency. Development (Cambridge, United Kingdom) 2002, 1075-1082.
139. McDaniell R., Warthen D.M., Sanchez-Lara P.A., Pai A., Krantz I.D., Piccoli D.A., Spinner N.B. NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the notch signaling pathway. American Journal of Human Genetics 2006, 169-173.
140. McElhinney D.B., Krantz I.D., Bason L., Piccoli D.A., Emerick K.M., Spinner N.B., Goldmuntz E. Analysis of cardiovascular phenotype and genotype-phenotype correlation in individuals with a JAG1 mutation and/or Alagille syndrome. Circulation 2002, 2567-2574.
141. McKellar S.H., Tester D.J., Yagubyan M., Majumdar R., Ackerman M.J., Sundt T.M. Novel NOTCH1 mutations in patients with bicuspid aortic valve disease and thoracic aortic aneurysms. The Journal of Thoracic and Cardiovascular Surgery 2007, 290-296.
142. Merki E., Zamora M., Raya A., Kawakami Y., Wang J., Zhang X., Burch J., Kubalak S.W., Kaliman P., Belmonte J.C., Chien K.R., Ruiz-Lozano P. Epicardial retinoid X receptor alpha is required for myocardial growth and coronary artery formation. Proceedings of the National Academy of Sciences of the United States of America 2005, 18455-18460.
143. Mikawa T., Gourdie R.G. Pericardial mesoderm generates a population of coronary smooth muscle cells migrating into the heart along with ingrowth of the epicardial organ. Developmental Biology (Amsterdam, Netherlands) 1996, 221-232.
144. Miquerol L., Langille B.L., Nagy A. Embryonic development is disrupted by modest increases in vascular endothelial growth factor gene expression. Development (Cambridge, United Kingdom) 2000, 3941-3946.
145. Molin D.G., Bartram U., Van der Heiden K., Van I.L., Speer C.P., Hierck B.P., Poelmann R.E., Gittenberger-de-Groot A.C. Expression patterns of Tgfbeta1-3 associate with myocardialisation of the outflow tract and the development of the epicardium and the fibrous heart skeleton. Developmental dynamics : An official publication of the American Association of Anatomists 2003, 431-444.
146. Molin D.G., Poelmann R.E., DeRuiter M.C., Azhar M., Doetschman T., Gittenberger-De Groot A.C. Transforming growth factor beta-SMAD2 signaling regulates aortic arch innervation and development. Circulation Research 2004, 1109-1117.
147. Molin D.G., Roest P.A., Nordstrand H., Wisse L.J., Poelmann R.E., Eriksson U.J., Gittenberger-De Groot A.C. Disturbed morphogenesis of cardiac outflow tract and increased rate of aortic arch anomalies in the offspring of diabetic rats. Birth Defects Research Part A, Clinical and Molecular Teratology 2004, 927-938.
148. Morrow D., Scheller A., Birney Y.A., Sweeney C., Guha S., Cummins P.M., Murphy R., Walls D., Redmond E.M., Cahill P.A. Notch-mediated CBF-1/RBP-J{kappa}-dependent regulation of human vascular smooth muscle cell phenotype in vitro. Am. J. Physiology Cell Physiology 2005, C1188-C1196.
149. Niessen K., Karsan A. Notch signaling in cardiac development. Circulation Research 2008, 1169-1181.
150. Nieto M.A., Sargent M.G., Wilkinson D.G., Cooke J. Control of cell behavior during vertebrate development by Slug, a zinc finger gene. Science 1994, 835-839.
151. Noguera-Troise I., Daly C., Papadopoulos N.J., Coetzee S., Boland P., Gale N.W., Lin H.C., Yancopoulos G.D., Thurston G. Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis. Nature 2006, 1032-1037.
152. Noseda M., McLean G., Niessen K., Chang L., Pollet I., Montpetit R., Shahidi R., Dorovini-Zis K., Li L., Beckstead B., Durand R.E., Hoodless P.A., Karsan A. Notch activation results in phenotypic and functional changes consistent with endothelial-to-mesenchymal transformation. Circulation Research 2004, 910-917.
153. Oda T., Elkahloun A.G., Pike B.L., Okajima K., Krantz I.D., Genin A., Piccoli D.A., Meltzer P.S., Spinner N.B., Collins F.S., Chandrasekharappa S.C. Mutations in the human Jagged1 gene are responsible for Alagille syndrome. Nature Genetics 1997, 235-242.
154. Olsson A.K., Dimberg A., Kreuger J., Claesson-Welsh L. VEGF receptor signalling - in control of vascular function. Nature Reviews Molecular Cell Biology 2006, 359-371.
155. Pan Q., Chanthery Y., Wu Y., Rahtore N., Tong R.K., Peale F., Bagri A., Tessier-Lavigne M., Koch A.W., Watts R.J. Neuropilin-1 binds to VEGF121 and regulates endothelial cell migration and sprouting. Journal of Biological Chemistry 2007, 24049-24056.
156. Pan Y., Liu Z., Shen J., Kopan R. Notch1 and 2 cooperate in limb ectoderm to receive an early Jagged2 signal regulating interdigital apoptosis. Developmental Biology (Amsterdam, Netherlands) 2005, 472-482.
157. Petrova T.V., Karpanen T., Norrmen C., Mellor R., Tamakoshi T., Finegold D., Ferrell R., Kerjaschki D., Mortimer P., Yla-Herttuala S., Miura N., Alitalo K. Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis. Nature Medicine (New York, NY, United States) 2004, 974-981.
158. Phng L.K., Gerhardt H. Angiogenesis: a team effort coordinated by notch. Developmental Cell 2009, 196-208.
159. Pinter E., Mahooti S., Wang Y., Imhof B.A., Madri J.A. Hyperglycemia-induced vasculopathy in the murine vitelline vasculature: correlation with PECAM-1/CD31 tyrosine phosphorylation state. The American Journal of Pathology 1999, 1367-1379.
160. Pitulescu M.E., Adams R.H. Eph/ephrin molecules--a hub for signaling and endocytosis. Genes and Development 2010, 2480-2492.
161. Poelmann R.E., Gittenberger-De Groot A.C. A subpopulation of apoptosis-prone cardiac neural crest cells targets to the venous pole: Multiple functions in heart development. Developmental Biology 1999, 271-286.
162. Poelmann R.E., Gittenberger-De Groot A.C., Mentink M.M.T., Bokenkamp R., Hogers B. Development of the cardiac coronary vascular endothelium, studied with antiendothelial antibodies, in chicken-quail chimeras. Circulation Research 1993, 559-568.
163. Poelmann R.E., Jongbloed M.R., Molin D.G., Fekkes M.L., Wang Z., Fishman G.I., Doetschman T., Azhar M., Gittenberger-De Groot A.C. The neural crest is contiguous with the cardiac conduction system in the mouse embryo: a role in induction? Anat. Embryology (Berlin) 2004, 389-393.
164. Poelmann R.E., Mikawa T., Gittenberger-De Groot A.C. Neural crest cells in outflow tract septation of the embryonic chicken heart: Differentiation and apoptosis. Developmental Dynamics 1998, 373-384.
165. Qiu Y., Hoareau-Aveilla C., Oltean S., Harper S.J., Bates D.O. The anti-angiogenic isoforms of VEGF in health and disease. Biochemical Society Transactions 2009, 1207-1213.
166. Red-Horse K., Ueno H., Weissman I.L., Krasnow M.A. Coronary arteries form by developmental reprogramming of venous cells. Nature 2010, 549-553.
167. Rentschler S., Harris B.S., Kuznekoff L., Jain R., Manderfield L., Lu M.M., Morley G.E., Patel V.V., Epstein J.A. Notch signaling regulates murine atrioventricular conduction and the formation of accessory pathways. Journal of Clinical Investigation 2011, 525-533.
168. Ridgway J., Zhang G., Wu Y., Stawicki S., Liang W.C., Chanthery Y., Kowalski J., Watts R.J., Callahan C., Kasman I., Singh M., Chien M., Tan C., Hongo J.A., de S.F., Plowman G., Yan M. Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis. Nature 2006, 1083-1087.
169. Riley M.F., McBride K.L., Cole S.E. NOTCH1 missense alleles associated with left ventricular outflow tract defects exhibit impaired receptor processing and defective EMT. Biochimica et Biophysica Acta 2011, 121-129.
170. Risau W. Mechanisms of angiogenesis. Nature 1997, 671-674.
171. Roberts D.M., Kearney J.B., Johnson J.H., Rosenberg M.P., Kumar R., Bautch V.L. The vascular endothelial growth factor (VEGF) receptor Flt-1 (VEGFR-1) modulates Flk-1 (VEGFR-2) signaling during blood vessel formation. The American Journal of Pathology 2004, 1531-1535.
172. Robinson C.J., Stringer S.E. The splice variants of vascular endothelial growth factor (VEGF) and their receptors. Journal of Cell Science 2001, 853-865.
173. Romano L.A., Runyan R.B. Slug is an essential target of TGFbeta2 signaling in the developing chicken heart. Developmental Biology (Amsterdam, Netherlands) 2000, 91-102.
174. Russell J.L., Goetsch S.C., Gaiano N.R., Hill J.A., Olson E.N., Schneider J.W. A dynamic notch injury response activates epicardium and contributes to fibrosis repair. Circulation Research 2011, 51-59.
175. Sainson R.C., Aoto J., Nakatsu M.N., Holderfield M., Conn E., Koller E., Hughes C.C. Cell-autonomous notch signaling regulates endothelial cell branching and proliferation during vascular tubulogenesis. FASEB Journal 2005, 1027-1029.
176. Scehnet J.S., Jiang W., Kumar S.R., Krasnoperov V., Trindade A., Benedito R., Djokovic D., Borges C., Ley E.J., Duarte A., Gill P.S. Inhibition of Dll4-mediated signaling induces proliferation of immature vessels and results in poor tissue perfusion. Blood 2007, 4753-4760.
177. Schlaeger T.M., Bartunkova S., Lawitts J.A., Teichmann G., Risau W., Deutsch U., Sato T.N. Uniform vascular-endothelial-cell-specific gene expression in both embryonic and adult transgenic mice. Proceedings of the National Academy of Sciences of the United States of America 1997, 3058-3063.
178. Seo S., Fujita H., Nakano A., Kang M., Duarte A., Kume T. The forkhead transcription factors, Foxc1 and Foxc2, are required for arterial specification and lymphatic sprouting during vascular development. Developmental Biology (Amsterdam, Netherlands) 2006, 458-470.
179. Shalaby F., Rossant J., Yamaguchi T.P., Gertsenstein M., Wu X.F., Breitman M.L., Schuh A.C. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 1995, 62-66.
180. Sharma P.R., Anderson R.H., Copp A.J., Henderson D.J. Spatiotemporal analysis of programmed cell death during mouse cardiac septation. The Anatomical Record Part A, Discoveries in Molecular, Cellular, and Evolutionary Biology 2004, 355-369.
181. Shawber C.J., Funahashi Y., Francisco E., Vorontchikhina M., Kitamura Y., Stowell S.A., Borisenko V., Feirt N., Podgrabinska S., Shiraishi K., Chawengsaksophak K., Rossant J., Accili D., Skobe M., Kitajewski J. Notch alters VEGF responsiveness in human and murine endothelial cells by direct regulation of VEGFR-3 expression. Journal of Clinical Investigation 2007, 3369-3382.
182. Shawber C.J., Kitajewski J. Notch function in the vasculature: insights from zebrafish, mouse and man. BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology 2004, 225-234.
183. Shibuya M. Vascular endothelial growth factor receptor-1 (VEGFR-1/Flt-1): a dual regulator for angiogenesis. Angiogenesis 2006, 225-230.
184. Shibuya M., Claesson-Welsh L. Signal Transduction by Vegf Receptors in Regulation of Angiogenesis and Lymphangiogenesis. Experimental Cell Research 2006, 549-560.
185. Shimizu K., Chiba S., Saito T., Kumano K., Takahashi T., Hirai H. Manic fringe and lunatic fringe modify different sites of the Notch2 extracellular region, resulting in different signaling modulation. Journal of Biological Chemistry 2001, 25753-25758.
186. Shraga-Heled N., Kessler O., Prahst C., Kroll J., Augustin H., Neufeld G. Neuropilin-1 and neuropilin-2 enhance VEGF121 stimulated signal transduction by the VEGFR-2 receptor. FASEB Journal 2007, 915-926.
187. Siekmann A.F., Covassin L., Lawson N.D. Modulation of VEGF signalling output by the Notch pathway. Bioessays : News And Reviews In Molecular, Cellular And Developmental Biology 2008, 303-313.
188. Siekmann A.F., Lawson N.D. Notch signalling limits angiogenic cell behaviour in developing zebrafish arteries. Nature 2007, 781-784.
189. Smedts H.P., Isaacs A., de C.D., Uitterlinden A.G., van Duijn C.M., Gittenberger-De Groot A.C., Helbing W.A., Steegers E.A., Steegers-Theunissen R.P. VEGF polymorphisms are associated with endocardial cushion defects: a family-based case-control study. Pediatric Research 2010, 23-28.
190. Sobti R.C., Maithil N., Thakur H., Sharma Y., Talwar K.K. VEGF and IL-4 gene variability and its association with the risk of coronary heart disease in north Indian population. Molecular and Cellular Biochemistry 2010, 139-148.
191. Soker S., Takashima S., Miao H.Q., Neufeld G., Klagsbrun M. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell (Cambridge, MA, United States) 1998, 735-745.
192. Song W., Jackson K., McGuire P.G. Degradation of type IV collagen by matrix metalloproteinases is an important step in the epithelial-mesenchymal transformation of the endocardial cushions. Developmental Biology (Amsterdam, Netherlands) 2000, 606-617.
193. Sorensen I., Adams R.H., Gossler A. DLL1-mediated Notch activation regulates endothelial identity in mouse fetal arteries. Blood 2009, 5680-5688.
194. Stalmans I., Lambrechts D., De Smet F., Jansen S., Wang J., Maity S., Kneer P., von der O.M., Swillen A., Maes C., Gewillig M., Molin D.G., Hellings P., Boetel T., Haardt M., Compernolle V., Dewerchin M., Plaisance S., Vlietinck R., Emanuel B., Gittenberger-De Groot A.C., Scambler P., Morrow B., Driscol D.A., Moons L., Esguerra C.V., Carmeliet G., Behn-Krappa A., Devriendt K., Collen D., Conway S.J., Carmeliet P. VEGF: a modifier of the del22q11 (DiGeorge) syndrome?. Nature Medicine (New York, NY, United States) 2003, 173-182.
195. Stalmans I., Ng Y.S., Rohan R., Fruttiger M., Bouche A., Yuce A., Fujisawa H., Hermans B., Shani M., Jansen S., Hicklin D., Anderson D.J., Gardiner T., Hammes H.P., Moons L., Dewerchin M., Collen D., Carmeliet P., D'Amore P.A. Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms. Journal of Clinical Investigation 2002, 327-336.
196. Stankunas K., Ma G.K., Kuhnert F.J., Kuo C.J., Chang C.P. VEGF signaling has distinct spatiotemporal roles during heart valve development. Developmental Biology (Amsterdam, Netherlands) 2010, 325-336.
197. Suchting S., Freitas C., le N.F., Benedito R., Breant C., Duarte A., Eichmann A. The Notch ligand Delta-like 4 negatively regulates endothelial tip cell formation and vessel branching. Proceedings of the National Academy of Sciences of the United States of America 2007, 3225-3230.
198. Sugishita Y., Leifer D.W., Agani F., Watanabe M., Fisher S.A. Hypoxia-responsive signaling regulates the apoptosis-dependent remodeling of the embryonic avian cardiac outflow tract. Developmental Biology (Amsterdam, Netherlands) 2004, 285-296.
199. Sugishita Y., Takahashi T., Shimizu T., Yao A., Kinugawa K., Sugishita K., Harada K., Matsui H., Nagai R. Expression of genes encoding vascular endothelial growth factor and its Flk-1 receptor in the chick embryonic heart. Journal of Molecular and Cellular Cardiology 2000, 1039-1051.
200. Sugishita Y., Watanabe M., Fisher S.A. Role of myocardial hypoxia in the remodeling of the embryonic avian cardiac outflow tract. Developmental Biology (Amsterdam, Netherlands) 2004, 294-308.
201. Swendeman S., Mendelson K., Weskamp G., Horiuchi K., Deutsch U., Scherle P., Hooper A., Rafii S., Blobel C.P. VEGF-A stimulates ADAM17-dependent shedding of VEGFR2 and crosstalk between VEGFR2 and ERK signaling. Circulation Research 2008, 916-918.
202. Taylor K.L., Henderson A.M., Hughes C.C. Notch activation during endothelial cell network formation in vitro targets the basic HLH transcription factor HESR-1 and downregulates VEGFR-2/KDR expression. Microvascular Research 2002, 372-383.
203. Timmerman L.A., Grego-Bessa J., Raya A., Bertran E., Perez-Pomares J.M., Diez J., Aranda S., Palomo S., McCormick F., Izpisua-Belmonte J.C., de la Pompa J.L. Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation. Genes and Development 2004, 99-115.
204. Tomanek R.J. Formation of the coronary vasculature: a brief review. Cardiovascular Research 1996, E46-E51.
205. Tomanek R.J., Ishii Y., Holifield J.S., Sjogren C.L., Hansen H.K., Mikawa T. VEGF family members regulate myocardial tubulogenesis and coronary artery formation in the embryo. Circulation Research 2006, 947-953.
206. Tomanek R.J., Ratajska A., Kitten G.T., Yue X., Sandra A. Vascular endothelial growth factor expression coincides with coronary vasculogenesis and angiogenesis. Developmental Dynamics : An Official Publication Of the American Association of Anatomists 1999, 54-61.
207. Trindade A., Kumar S.R., Scehnet J.S., Lopes-da-Costa L., Becker J., Jiang W., Liu R., Gill P.S., Duarte A. Overexpression of delta-like 4 induces arterialization and attenuates vessel formation in developing mouse embryos. Blood 2008, 1720-1729.
208. van Bueren K.L., Papangeli I., Rochais F., Pearce K., Roberts C., Calmont A., Szumska D., Kelly R.G., Bhattacharya S., Scambler P.J. Hes1 expression is reduced in Tbx1 null cells and is required for the development of structures affected in 22q11 deletion syndrome. Developmental Biology (Amsterdam, Netherlands) 2010, 369-380.
209. Van Den Akker N.M., Caolo V., Wisse L.J., Peters P.P., Poelmann R.E., Carmeliet P., Molin D.G., Gittenberger-De Groot A.C. Developmental coronary maturation is disturbed by aberrant cardiac vascular endothelial growth factor expression and Notch signalling. Cardiovascular Research 2008, 366-375.
210. Van Den Akker N.M., Molin D.G., Peters P.P., Maas S., Wisse L.J., van B.R., van Munsteren C.J., Bartelings M.M., Poelmann R.E., Carmeliet P., Gittenberger-De Groot A.C. Tetralogy of Fallot and alterations in vascular endothelial growth factor-A signaling and notch signaling in mouse embryos solely expressing the VEGF120 isoform. Circulation Research 2007, 842-849.
211. Van Den Akker N.M., Winkel L.C., Nisancioglu M.H., Maas S., Wisse L.J., Armulik A., Poelmann R.E., Lie-Venema H., Betsholtz C., Gittenberger-De Groot A.C. PDGF-B signaling is important for murine cardiac development: its role in developing atrioventricular valves, coronaries, and cardiac innervation. Developmental Dynamics : An Official Publication of the American Association of Anatomists 2008, 494-503.
212. Vannay A., Vasarhelyi B., Kornyei M., Treszl A., Kozma G., Gyorffy B., Tulassay T., Sulyok E. Single-nucleotide polymorphisms of VEGF gene are associated with risk of congenital valvuloseptal heart defects. American Heart Journal 2006, 878-881.
213. Venkatesh D., Fredette N., Rostama B., Tang Y., Vary C.P., Liaw L., Urs S. RhoA-mediated signaling in Notch-induced senescence-like growth arrest and endothelial barrier dysfunction. Arteriosclerosis, Thrombosis, and Vascular Biology 2011, 876-882.
214. Villa N., Walker L., Lindsell C.E., Gasson J., Iruela-Arispe M.L., Weinmaster G. Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. Mechanisms of Development 2001, 161-164.
215. Visconti R.P., Richardson C.D., Sato T.N. Orchestration of angiogenesis and arteriovenous contribution by angiopoietins and vascular endothelial growth factor (VEGF). Proceedings of the National Academy of Sciences of the United States of America 2002, 8219-8224.
216. Vooijs M., Ong C.T., Hadland B., Huppert S., Liu Z., Korving J., van den Born M., Stappenbeck T., Wu Y., Clevers H., Kopan R. Mapping the consequence of Notch1 proteolysis in vivo with NIP-CRE. Development (Cambridge, United Kingdom) 2007, 535-544.
217. Vrancken Peeters M.P., Gittenberger-De Groot A.C., Mentink M.M., Hungerford J.E., Little C.D., Poelmann R.E. The development of the coronary vessels and their differentiation into arteries and veins in the embryonic quail heart. Developmental dynamics : an Official Publication of the American Association of Anatomists 1997, 338-348.
218. Vrancken Peeters M.P., Mentink M.M., Poelmann R.E., Gittenberger-De Groot A.C. Cytokeratins as a marker for epicardial formation in the quail embryo. Anatomy and Embryology (Berlin) 1995, 503-508.
219. Wada A.M., Smith T.K., Osler M.E., Reese D.E., Bader D.M. Epicardial/Mesothelial cell line retains vasculogenic potential of embryonic epicardium. Circulation Research 2003, 525-531.
220. Waldo K., Miyagawa-Tomita S., Kumiski D., Kirby M.L. Cardiac neural crest cells provide new insight into septation of the cardiac outflow tract: aortic sac to ventricular septal closure. Developmental Biology (Amsterdam, Netherlands) 1998, 129-144.
221. Waldo K., Zdanowicz M., Burch J., Kumiski D.H., Stadt H.A., Godt R.E., Creazzo T.L., Kirby M.L. A novel role for cardiac neural crest in heart development. Journal of Clinical Investigation 1999, 1499-1507.
222. Waldo K.L., Hutson M.R., Stadt H.A., Zdanowicz M., Zdanowicz J., Kirby M.L. Cardiac neural crest is necessary for normal addition of the myocardium to the arterial pole from the secondary heart field. Developmental Biology (Amsterdam, Netherlands) 2005, 66-77.
223. Wang Y., Zheng Y., Zhang W., Yu H., Lou K., Zhang Y., Qin Q., Zhao B., Yang Y., Hui R. Polymorphisms of KDR gene are associated with coronary heart disease. Journal of the American College of Cardiology 2007, 760-767.
224. Ward C., Stadt H., Hutson M., Kirby M.L. Ablation of the secondary heart field leads to tetralogy of Fallot and pulmonary atresia. Developmental Biology (Amsterdam, Netherlands) 2005, 72-83.
225. Washington Smoak I., Byrd N.A., Abu-Issa R., Goddeeris M.M., Anderson R., Morris J., Yamamura K., Klingensmith J., Meyers E.N. Sonic hedgehog is required for cardiac outflow tract and neural crest cell development. Developmental Biology (Amsterdam, Netherlands) 2005, 357-372.
226. Watanabe M., Choudhry A., Berlan M., Singal A., Siwik E., Mohr S., Fisher S.A. Developmental remodeling and shortening of the cardiac outflow tract involves myocyte programmed cell death. Development (Cambridge, United Kingdom) 1998, 3809-3820.
227. Watanabe Y., Kokubo H., Miyagawa-Tomita S., Endo M., Igarashi K., Aisaki K.I., Kanno J., Saga Y. Activation of Notch1 signaling in cardiogenic mesoderm induces abnormal heart morphogenesis in mouse. Development (Cambridge, United Kingdom) 2006, 1625-1634.
228. Wessels A., Perez-Pomares J.M. The epicardium and epicardially derived cells (EPDCs) as cardiac stem cells. The Anatomical Record Part A, Discoveries in Molecular, Cellular, and Evolutionary Biology 2004, 43-57.
229. Williams C.K., Li J.L., Murga M., Harris A.L., Tosato G. Up-regulation of the Notch ligand Delta-like 4 inhibits VEGF-induced endothelial cell function. Blood 2006, 931-939.
230. Wilting J., Buttler K., Schulte I., Papoutsi M., Schweigerer L., Manner J. The proepicardium delivers hemangioblasts but not lymphangioblasts to the developing heart. Developmental Biology (Amsterdam, Netherlands) 2007, 451-459.
231. Xia Y., Bhattacharyya A., Roszell E.E., Sandig M., Mequanint K. The role of endothelial cell-bound Jagged1 in Notch3-induced human coronary artery smooth muscle cell differentiation. Biomaterials 2012, 2462-2472.
232. Xie J., Yi L., Xu Z.F., Mo X.M., Hu Y.L., Wang D.J., Ren H.Z., Han B., Wang Y., Yang C., Zhao Y.L., Shi D.Q., Jiang Y.Z., Shen L., Qiao D., Chen S.L., Yu B.J. VEGF C-634G polymorphism is associated with protection from isolated ventricular septal defect: case-control and TDT studies. Eur. Journal of Human Genetics 2007, 1246-1251.
233. Yang K., Doughman Y.Q., Karunamuni G., Gu S., Yang Y.C., Bader D.M., Watanabe M. Expression of active Notch1 in avian coronary development. Developmental Dynamics : An Official Publication of the American Association of Anatomists 2009, 162-170.
234. Yelbuz T.M., Waldo K.L., Kumiski D.H., Stadt H.A., Wolfe R.R., Leatherbury L., Kirby M.L. Shortened outflow tract leads to altered cardiac looping after neural crest ablation. Circulation 2002, 504-510.
235. Yla-Herttuala S., Rissanen T.T., Vajanto I., Hartikainen J. Vascular endothelial growth factors: biology and current status of clinical applications in cardiovascular medicine. Journal of the American College of Cardiology 2007, 1015-1026.
236. You L.R., Lin F.J., Lee C.T., Demayo F.J., Tsai M.J., Tsai S.Y. Suppression of Notch signalling by the COUP-TFII transcription factor regulates vein identity. Nature 2005, 98-104.
237. Zaffran S., Kelly R.G. New developments in the second heart field, combining the pharyngeal mesoderm with Hox gene expression, and FGF signaling including the role of the Tbx family. Differentiation (Malden, MA, United States) 2012.
238. Zavadil J., Cermak L., Soto-Nieves N., Bottinger E.P. Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition. EMBO Journal 2004, 1155-1165.
239. Zhang C., Tian L., Chi C., Wu X., Yang X., Han M., Xu T., Zhuang Y., Deng K. Adam10 is essential for early embryonic cardiovascular development. Developmental Dynamics : An Official Publication of the American Association of Anatomists 2010, 2594-2602.
240. Zhao W., Wang J., Shen J., Sun K., Zhu J., Yu T., Ji W., Chen Y., Fu Q., Li F. Mutations in VEGFA are associated with congenital left ventricular outflow tract obstruction. Biochemical and Biophysical Research Communications 2010, 483-488.